Chemed CHE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 32.4%-2.4pp | 32.5%-2.6pp | 32.9%-2.8pp | 33.6%-2.3pp | 34.8%-0.6pp | |
| Operating margin | 12.9%-2.7pp | 13.4%-1.7pp | 13.9%-1.4pp | 14.7%-0.7pp | 15.6%+0.8pp | |
| Net margin | 10.2%-2.2pp | 10.5%-1.9pp | 11%-1.7pp | 11.6%-1.3pp | 12.4%0.0pp | |
| EBITDA margin | 15.5%-2.7pp | 15.9%-1.7pp | 16.4%-1.5pp | 17.2%-0.8pp | 18.2%+0.6pp | |
| Free cash flow margin | 14.8%+2.2pp | 12.9%-2.3pp | 14.2%+1.1pp | 14.8%+4.0pp | 12.7%-0.5pp | |
| Returns | ||||||
| Return on equity | 25.6%-0.5pp | 25.3%-1.8pp | 24.1%-2.6pp | 24.1%-3.7pp | 26.1%-1.4pp | |
| Return on assets | 15.9%-2.0pp | 16.5%-1.6pp | 16.4%-1.7pp | 16.8%-1.8pp | 17.9%-0.1pp | |
| Return on invested capital | 25.1%-5.4pp | 27%-3.4pp | 27%-2.1pp | 28.3%-1.6pp | 30.6%+1.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.6×+0.1× | 1.6×+0.1× | 1.5×+0.1× | 1.5×0.0× | 1.4×0.0× | |
| Inventory turnover | 229.1×+53.7× | 216.9×+60.8× | 187.3×+50.8× | 167.7×+34.2× | 175.4×+36.9× | |
| Liquidity | ||||||
| Current ratio | 0.9×-0.9× | 1.1×-0.3× | 1.4×-0.5× | 1.9×+0.1× | 1.7×-0.2× | |
| Quick ratio | 0.8×-0.9× | 1×-0.3× | 1.3×-0.5× | 1.8×+0.1× | 1.7×-0.2× | |
| Cash ratio | 0.1×-0.5× | 0.3×-0.4× | 0.4×-0.5× | 0.9×+0.1× | 0.6×-0.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | 0.6×+0.6× | 0.2×+0.3× | 0×+0.2× | -0.2×-0.1× | -0.1×+0.4× | |
| Interest coverage | 169.7×-61.2× | 193.3×-12.6× | 203.4×-20.9× | 217.2×-1.5× | 230.9×+59.4× | |
| Per Share | ||||||
| Book value per share | $61.94-22.6% | $67.73-8.1% | $74.72-8.3% | $81.51+3.0% | $80.04+3.7% | |
| Valuation | ||||||
| Market capitalization | $5.2B-42.3% | $6.04B-24.0% | $6.52B-28.1% | $8.15B-0.6% | $9.01B-7.2% | |
| Enterprise value | $5.42B-39.6% | $6.11B-22.7% | $6.54B-27.2% | $8.05B-1.0% | $8.98B-5.9% | |
| Price / earnings | 20×-9.2× | 22.8×-3.5× | 23.4×-6.7× | 28.1×+0.8× | 29.2×-5.1× | |
| Price / sales | 2×-1.6× | 2.4×-0.9× | 2.6×-1.2× | 3.2×-0.3× | 3.6×-0.6× | |
| Price / book | 6.1×-1.5× | 6.2×-0.9× | 6.1×-1.3× | 6.8×0.0× | 7.6×-0.6× | |
| EV / EBITDA | 13.8×-6.1× | 15.1×-3.2× | 15.7×-5.3× | 18.6×-0.7× | 19.9×-3.9× | |
| EV / sales | 2.1×-1.5× | 2.4×-0.8× | 2.6×-1.2× | 3.2×-0.3× | 3.6×-0.6× | |
| Free cash flow yield | 7.3%+3.8pp | 5.4%+0.8pp | 5.5%+2.1pp | 4.6%+1.5pp | 3.5%+0.4pp | |
| Earnings yield | 5%+1.6pp | 4.4%+0.6pp | 4.3%+0.9pp | 3.6%-0.1pp | 3.4%+0.5pp | |
| Dividend yield | 0.6%+0.3pp | 0.5%+0.2pp | 0.5%+0.2pp | 0.4%+0.1pp | 0.3%+0.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Chemed's profit margins?
- Chemed (CHE) runs a 32.4% gross margin and a 12.9% operating margin, with a 10.2% net margin.
- Where do Chemed's ratios come from?
- Every ratio is computed from Chemed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
